These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12748329)

  • 1. Marked increase in serum IgM during treatment of Waldenstrom's macroglobulinemia with cladribine.
    Krishna VM; Carey RW; Bloch KJ
    N Engl J Med; 2003 May; 348(20):2045-6. PubMed ID: 12748329
    [No Abstract]   [Full Text] [Related]  

  • 2. 2-Chlorodeoxyadenosine treatment of Waldenström's macroglobulinemia--the analysis of own experience and the review of literature.
    Lewandowski K; Zaucha JM; Bieniaszewska M; Hałaburda K; Hellmann A
    Med Sci Monit; 2000; 6(4):740-5. PubMed ID: 11208402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis and treatment of Waldenström's macroglobulinemia.
    Louw VJ; Webb MJ
    Transfus Apher Sci; 2010 Apr; 42(2):193-7. PubMed ID: 20117052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fludarabine therapy in a patient with progressive symptomatic Waldenström's macroglobulinemia.
    Hałaburda K; Hellmann A
    Acta Haematol Pol; 1994; 25(1):63-7. PubMed ID: 8209618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-onset autoimmune hemolytic anemia after cladribine therapy for Waldenström's macroglobulinemia.
    Aslan DL; Peterson BA; Long-Tsai M; Eastlund T
    Transfusion; 2006 Jan; 46(1):90-4. PubMed ID: 16398735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Chloro-2'-deoxyadenosine (2-CdA) treatment in a patient with Waldenström's macroglobulinaemia complicated by severe neutrocytopenia.
    Zaucha JM; Ciesielski D; Grieb P; Hellmann A
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):35-7. PubMed ID: 7503632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?
    Bladé J; Montoto S; Rosiñol L; Montserrat E
    Semin Oncol; 2003 Apr; 30(2):329-31. PubMed ID: 12720163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial immunoglobulin M 'flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study.
    Ghobrial IM; Fonseca R; Greipp PR; Blood E; Rue M; Vesole DH; Gertz MA;
    Cancer; 2004 Dec; 101(11):2593-8. PubMed ID: 15493038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Waldenstrom's macroglobulinemia with nucleoside analogues.
    Dimopoulos MA; O'Brien S; Kantarjian H; Estey EE; Keating MJ; Alexanian R
    Leuk Lymphoma; 1993; 11 Suppl 2():105-8. PubMed ID: 7907250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia.
    Weber DM; Dimopoulos MA; Delasalle K; Rankin K; Gavino M; Alexanian R
    Semin Oncol; 2003 Apr; 30(2):243-7. PubMed ID: 12720145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab-based treatments in Waldenström's macroglobulinemia.
    Dimopoulos MA; Kastritis E; Roussou M; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Tassidou A; Terpos E
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):59-61. PubMed ID: 19362975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of meningeal Waldenström's macroglobulinemia to 2-chlorodeoxyadenosine.
    Richards AI
    J Clin Oncol; 1995 Sep; 13(9):2476. PubMed ID: 7666113
    [No Abstract]   [Full Text] [Related]  

  • 14. Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248.
    Treon SP; Hunter ZR; Matous J; Joyce RM; Mannion B; Advani R; Cook D; Songer J; Hill J; Kaden BR; Sharon D; Steiss R; Leleu X; Branagan AR; Badros A
    Clin Cancer Res; 2007 Jun; 13(11):3320-5. PubMed ID: 17545538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The International Prognostic Scoring System for Waldenstrom's macroglobulinemia is applicable in patients treated with rituximab-based regimens.
    Dimopoulos MA; Kastritis E; Delimpassi S; Zomas A; Kyrtsonis MC; Zervas K
    Haematologica; 2008 Sep; 93(9):1420-2. PubMed ID: 18641029
    [No Abstract]   [Full Text] [Related]  

  • 16. Dissociable IgM-albumin interaction in a case of Waldenström's macroglobulinemia.
    Ropars C; Saleun JP; Bergeret G; Doinel C
    Rev Eur Etud Clin Biol; 1972 Nov; 17(9):854-9. PubMed ID: 4631794
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiation therapy and combination of cladribine, cyclophosphamide, and prednisone as treatment of Bing-Neel syndrome: Case report and review of the literature.
    Delgado J; Canales MA; Garcia B; Alvarez-Ferreira J; Garcia-Grande A; Hernandez-Navarro F
    Am J Hematol; 2002 Feb; 69(2):127-31. PubMed ID: 11835349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waldenström's macroglobulinemia.
    Gertz MA; Fonseca R; Rajkumar SV
    Oncologist; 2000; 5(1):63-7. PubMed ID: 10706651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemical studies in a patient with Waldenstrom's macroglobulinemia.
    Mir-Ahmadian M; Rahbar S; Heidery H; Hajaliloo G
    Acta Med Iran; 1978; 21(1):39-46. PubMed ID: 110036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation?
    Ling S; Joshua DE; Gibson J; Young G; Iland H; Watson G; Ho PJ
    Am J Hematol; 2006 Feb; 81(2):110-4. PubMed ID: 16432856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.